Nipro TrueResult - Healthcare Professional Health and Safety Information; Professional Use Warnings

FOR HEALTHCARE PROFESSIONALS
IMPORTANT HEALTH and SAFETY
INFORMATION:
DO NOT use the TRUEresult System for patients
receiving the following treatments:
• Peritoneal dialysis using solutions containing
icodextrin (Extraneal
®
, Icodial
®
) that is metabolized to
maltose,
• Injections or infusions of solutions containing
galactose or maltose, including some human
immunoglobulin preparations (Octagam
®
, WinRho
®
,
SDF Liquid, HepaGam B
™
),
• Xylose absorption testing,
• Intravenous solutions containing maltose,
• Any drugs that contain or metabolize to maltose,
galactose, or xylose (Orencia
®
, Adept
®
, Bexxar
®
).
Using the TRUEresult System when receiving the
above treatments may cause false high glucose
results. False high results may lead to inappropriate
therapy, which may result in coma or death. For more
information, see www.fda.gov/BiologicsBloodVaccines/
SafetyAvailability/ucm154213.htm.
Additional instructions for use of the System in a
professional multi-patient setting are included in
the Quality Assurance/Quality Control Manual.
e QA/QC Manual is available on our website
www.niprodiagnostics.com, or call 1-800-803-6049
or 1-954-677-4599.
4